T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Rayonier Advanced Materials
RYAM
$576M
| $105K | ﹤0.01% |
10,909
+760
| +7% | +$4.84K |
|
|
BBBY
2702
DELISTED
Bed Bath & Beyond Inc
BBBY
| $105K | ﹤0.01% |
41,732
-1,229
| -3% | -$4.82K |
|
2703
Dare Bioscience
DARE
$20.1M
| $104K | ﹤0.01% |
10,492
| – | – |
|
2704
Lineage Cell Therapeutics
LCTX
$271M
| $104K | ﹤0.01% |
89,100
| – | – |
|
|
MCW
2705
DELISTED
Mister Car Wash
MCW
| $104K | ﹤0.01% |
11,262
+77
| +0.7% | +$714 |
|
|
GAN
2706
DELISTED
GAN Ltd
GAN
| $103K | ﹤0.01% |
68,600
| – | – |
|
2707
indie Semiconductor
INDI
$830M
| $103K | ﹤0.01% |
17,729
+1,181
| +7% | +$8.71K |
|
|
BMTX
2708
DELISTED
BM Technologies, Inc.
BMTX
| $103K | ﹤0.01% |
19,800
+9,200
| +87% | +$58.7K |
|
2709
DocGo
DCGO
$64.2M
| $102K | ﹤0.01% |
14,443
+1,638
| +13% | +$13.7K |
|
2710
Rackspace Technology
RXT
$1.07B
| $101K | ﹤0.01% |
34,270
+831
| +2% | +$3.51K |
|
2711
Avita Medical
RCEL
$253M
| $100K | ﹤0.01% |
15,100
| – | – |
|
2712
Aurinia Pharmaceuticals
AUPH
$2.01B
| $99K | ﹤0.01% |
23,021
+1,563
| +7% | +$9.07K |
|
|
XRN
2713
Chiron Real Estate Inc
XRN
$486M
| $99K | ﹤0.01% |
+2,090
| New | +$94.5K |
|
2714
Standard BioTools
LAB
$307M
| $99K | ﹤0.01% |
84,900
+23,100
| +37% | +$28.4K |
|
|
VAPO
2715
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $97K | ﹤0.01% |
4,519
| – | – |
|
2716
Akebia Therapeutics
AKBA
$247M
| $96K | ﹤0.01% |
166,900
| – | – |
|
2717
LifeVantage
LFVN
$81.5M
| $96K | ﹤0.01% |
25,900
| – | – |
|
2718
Stereotaxis
STXS
$138M
| $96K | ﹤0.01% |
46,300
+12,700
| +38% | +$24.8K |
|
2719
Citizens
CIA
$201M
| $95K | ﹤0.01% |
44,500
| – | – |
|
2720
AvePoint
AVPT
$2.75B
| $94K | ﹤0.01% |
22,865
+2,901
| +15% | +$12.4K |
|
2721
Wave Life Sciences
WVE
$1.07B
| $94K | ﹤0.01% |
13,459
-29,621
| -69% | -$136K |
|
|
SAFE
2722
Safehold
SAFE
$1.1B
| $93K | ﹤0.01% |
1,957
-255
| -12% | -$12.3K |
|
|
FIRY
2723
Firy Inc
FIRY
$162M
| $93K | ﹤0.01% |
9,143
-4,157
| -31% | -$76.4K |
|
|
VTNR
2724
DELISTED
Vertex Energy, Inc
VTNR
| $93K | ﹤0.01% |
14,964
+771
| +5% | +$5.76K |
|
|
BGFV
2725
DELISTED
Big 5 Sporting Goods
BGFV
| $92K | ﹤0.01% |
10,468
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.